Related Experiment Video
Updated: Feb 8, 2026

Efficient Generation Human Induced Pluripotent Stem Cells from Human Somatic Cells with Sendai-virus
Published on: April 23, 2014
Targeted Elimination of Tumorigenic Human Pluripotent Stem Cells Using Suicide-Inducing Virus-like Particles
Antonio Rampoldi1, Stephen N Crooke2, Marcela K Preininger1,3
1Department of Pediatrics , Emory University School of Medicine and Children's Healthcare of Atlanta , Atlanta , Georgia 30322 , United States.
Abstract:
Sensitization to prodrugs via transgenic expression of suicide genes is a leading strategy for the selective elimination of potentially tumorigenic human pluripotent stem cells (hPSCs) in regenerative medicine, but transgenic modification poses safety risks such as deleterious mutagenesis. We describe here an alternative method of delivering suicide-inducing molecules explicitly to hPSCs using virus-like particles (VLPs) and demonstrate its use in eliminating undifferentiated hPSCs in vitro. VLPs were engineered from Qβ bacteriophage capsids to contain enhanced green fluorescent protein (EGFP) or cytosine deaminase (CD) and to simultaneously display multiple IgG-binding ZZ domains. After labeling with antibodies against the hPSC-specific surface glycan SSEA-5, EGFP-containing particles were shown to specifically bind undifferentiated cells in culture, and CD-containing particles were able to eliminate undifferentiated hPSCs with virtually no cytotoxicity to differentiated cells upon treatment with the prodrug 5-fluorocytosine.
Insights
Researchers developed virus-like particles (VLPs) to target and eliminate undifferentiated human pluripotent stem cells (hPSCs) without genetic modification, offering a safer alternative for regenerative medicine applications.
Area of Science:
- Regenerative Medicine
- Stem Cell Biology
- Biotechnology
Background:
- Transgenic suicide gene therapy is a key strategy for eliminating tumorigenic human pluripotent stem cells (hPSCs) in regenerative medicine.
- However, transgenic modification carries safety risks, including deleterious mutagenesis.
Purpose of the Study:
- To develop a non-transgenic method for delivering suicide-inducing molecules specifically to hPSCs.
- To demonstrate the efficacy of virus-like particles (VLPs) for eliminating undifferentiated hPSCs in vitro.
Main Methods:
- Engineered Qβ bacteriophage capsids into VLPs containing enhanced green fluorescent protein (EGFP) or cytosine deaminase (CD).
- Displayed IgG-binding ZZ domains on VLPs for targeted delivery.
- Labeled VLPs with antibodies against the hPSC-specific surface glycan SSEA-5.
- Assessed binding specificity to undifferentiated hPSCs and cytotoxicity to differentiated cells.
Main Results:
- EGFP-containing VLPs specifically bound to undifferentiated hPSCs in culture.
- CD-containing VLPs effectively eliminated undifferentiated hPSCs when treated with the prodrug 5-fluorocytosine.
- Minimal cytotoxicity was observed in differentiated cells.
Conclusions:
- Virus-like particles offer a safe and effective method for targeted elimination of undifferentiated hPSCs.
- This VLP-based approach provides a promising alternative to transgenic strategies in regenerative medicine.
Related Concept Videos
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic...
Embryonic Stem Cells
What are Viruses?
Adult Stem Cells
Subatomic Particles

